CA Patent

CA3108544A1 — Methods for purification of messenger rna

Assigned to Translate Bio Inc · Expires 2020-02-27 · 6y expired

What this patent protects

The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.

USPTO Abstract

The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.

Drugs covered by this patent

vutrisiran-sodium (VUTRISIRAN SODIUM)

Patent Metadata

Patent number: CA3108544A1
Jurisdiction: CA
Classification: —
Expires: 2020-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Translate Bio Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.